Literature DB >> 15349911

Hepatitis C virus NS5A-regulated gene expression and signaling revealed via microarray and comparative promoter analyses.

Sophie Girard1, Erik Vossman, David E Misek, Philippe Podevin, Samir Hanash, Christian Bréchot, Laura Beretta.   

Abstract

Most individuals exposed to hepatitis C virus (HCV) become chronically infected and are predisposed to liver disease. The mechanisms underlying viral persistence and disease progression are unknown. A role for the HCV NS5A protein in viral replication and interferon resistance has been demonstrated. To identify mechanisms affected by NS5A, we analyzed the gene expression of Huh7 cells expressing NS5A and control cells using oligonucleotide microarrays. A set of 103 genes (43 up-regulated, 60 down-regulated) whose expression was modified by at least twofold was selected. These included genes involved in cell adhesion and motility, calcium homeostasis, lipid transport and metabolism, and genes regulating immune responses. The finding of modulated expression of genes related to the TGF-beta superfamily and liver fibrosis was observed. Interestingly, both the tumor necrosis factor and lymphotoxin beta receptors were down-regulated by NS5A. Similar data were obtained following expression of four NS5A mutants obtained from patients who were not responsive or were sensitive to interferon therapy. Through computational analysis, we determined that 39 of the 43 genes up-regulated by NS5A contained one or more nuclear factor kappaB (NF-kappaB) binding sites within their promoter region. Using the Gibbs sampling method, we also detected enrichment of NF-kappaB consensus binding sites in the upstream regions of the 43 coexpressed genes. Activation of NF-kappaB by NS5A was subsequently demonstrated in luciferase reporter assays. Adenovirus-mediated expression of IkappaBalpha reverted NS5A mediated up-regulation of gene expression. In conclusion, this study suggests a role of NS5A and NF-kappaB in HCV pathogenesis and related liver disease. Supplementary material for this article can be found on the HEPATOLOGY website (http://interscience.wiley.com/jpages/0270-9139/suppmat/index.html). Copyright 2004 American Association for the Study of Liver Diseases

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15349911     DOI: 10.1002/hep.20371

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

1.  Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent.

Authors:  K S O'Connor; G Parnell; E Patrick; G Ahlenstiel; V Suppiah; D van der Poorten; S A Read; R Leung; M W Douglas; J Y H Yang; G J Stewart; C Liddle; J George; D R Booth
Journal:  Genes Immun       Date:  2014-01-16       Impact factor: 2.676

2.  Direct, interferon-independent activation of the CXCL10 promoter by NF-κB and interferon regulatory factor 3 during hepatitis C virus infection.

Authors:  Jessica Brownell; Jacob Bruckner; Jessica Wagoner; Emmanuel Thomas; Yueh-Ming Loo; Michael Gale; T Jake Liang; Stephen J Polyak
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

3.  High expression of APOBEC3G in patients infected with hepatitis C virus.

Authors:  Yoshihiro Komohara; Hirohisa Yano; Shigeki Shichijo; Kunitada Shimotohno; Kyogo Itoh; Akira Yamada
Journal:  J Mol Histol       Date:  2006-10-12       Impact factor: 2.611

Review 4.  Chemokines in the immunopathogenesis of hepatitis C infection.

Authors:  Mathis Heydtmann; David H Adams
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

5.  Responses of nontransformed human hepatocytes to conditional expression of full-length hepatitis C virus open reading frame.

Authors:  Weiliang Tang; Catherine A Lázaro; Jean S Campbell; W Tony Parks; Michael G Katze; Nelson Fausto
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

6.  The hepatic transcriptome in human liver disease.

Authors:  Nicholas A Shackel; Devanshi Seth; Paul S Haber; Mark D Gorrell; Geoffrey W McCaughan
Journal:  Comp Hepatol       Date:  2006-11-07

7.  The hepatitis C virus non-structural NS5A protein impairs both the innate and adaptive hepatic immune response in vivo.

Authors:  Malte Kriegs; Tilmann Bürckstümmer; Kyoshi Himmelsbach; Michael Bruns; Lars Frelin; Gustaf Ahlén; Matti Sällberg; Eberhard Hildt
Journal:  J Biol Chem       Date:  2009-08-12       Impact factor: 5.157

8.  The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production.

Authors:  Oscar Gonzalez; Vanessa Fontanes; Santanu Raychaudhuri; Rachel Loo; Joseph Loo; Vaithilingaraja Arumugaswami; Ren Sun; Asim Dasgupta; Samuel W French
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

9.  Activation of ribosomal RNA transcription by hepatitis C virus involves upstream binding factor phosphorylation via induction of cyclin D1.

Authors:  Santanu Raychaudhuri; Vanessa Fontanes; Bhaswati Barat; Asim Dasgupta
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

10.  Inhibition of HCV by the serpin antithrombin III.

Authors:  Mohammed Asmal; Michael Seaman; Wenyu Lin; Raymond T Chung; Norman L Letvin; Ralf Geiben-Lynn
Journal:  Virol J       Date:  2012-10-02       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.